利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

6 条记录 (耗时 0.021 秒)

    Use of acylaminothiazole derivatives as therapeutic agents
    1.
    发明授权
    Use of acylaminothiazole derivatives as therapeutic agents 失效
    酰基氨基噻唑衍生物作为治疗剂的用途

    公开(公告)号：US07795289B2

    公开(公告)日：2010-09-14

    申请号：US11859443

    申请日：2007-09-21

    申请人： Sylvie Baltzer ,  Bruno Schoentjes ,  Viviane Van Dorsselaer

    发明人： Sylvie Baltzer ,  Bruno Schoentjes ,  Viviane Van Dorsselaer

    IPC分类号： A61K31/426

    CPC分类号： C07D417/12 ,  C07D277/56

    摘要： This invention discloses and claims a method of treatment of a disease as defined herein using a compound conforming to the general formula (I): Wherein R1, R2, R′2, R3, R4 and R5 are as described herein. Specifically, the compounds of the present invention exhibit an inhibitory effect on the production of β-amyloid peptide (β-A4) by inhibition of gamma protease. Therefore, the compounds of the present invention are useful in the treatment of pathologies such as senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy and/or cerebrovascular disorders.

    摘要翻译： 本发明公开并要求使用符合通式（I）的化合物治疗本文定义的疾病的方法：其中R 1，R 2，R'2，R 3，R 4和R 5如本文所述。 具体地，本发明的化合物通过抑制γ蛋白酶表现出对β-淀粉样蛋白肽（＆bgr; -A4）的产生的抑制作用。 因此，本发明的化合物可用于治疗老年性痴呆，阿尔茨海默氏病，唐氏综合征，帕金森病，淀粉样血管病和/或脑血管障碍等病态。

    Acylaminothiazole derivatives, preparation and therapeutic use thereof
    2.
    发明授权
    Acylaminothiazole derivatives, preparation and therapeutic use thereof 失效
    酰氨基噻唑衍生物，其制备和治疗用途

    公开(公告)号：US07291636B2

    公开(公告)日：2007-11-06

    申请号：US11035803

    申请日：2005-01-14

    申请人： Sylvie Baltzer ,  Bruno Schoentjes ,  Viviane Van Dorsselaer

    发明人： Sylvie Baltzer ,  Bruno Schoentjes ,  Viviane Van Dorsselaer

    IPC分类号： A61K31/426 ,  C07D277/46

    CPC分类号： C07D417/12 ,  C07D277/56

    摘要： This invention discloses and claims a compound conforming to the general formula (I): Wherein R1, R2, R′2, R3, R4 and R5 are as described herein. The compounds of the present invention exhibit an inhibitory effect on the production of β-amyloid peptide (β-A4) by inhibition of gamma protease. Therefore, the compounds of the present invention are useful in the treatment of pathologies such as senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy and/or cerebrovascular disorders.

    摘要翻译： 本发明公开了一种符合通式（I）的化合物：其中R 1，R 2，R 2，R 2， R 3，R 4和R 5如本文所述。 本发明的化合物通过抑制γ蛋白酶对β-淀粉样蛋白肽（β-A4）的产生具有抑制作用。 因此，本发明的化合物可用于治疗老年性痴呆，阿尔茨海默氏病，唐氏综合征，帕金森病，淀粉样血管病和/或脑血管障碍等病态。

    Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors
    3.
    发明授权
    Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors 失效
    酰氨基噻唑衍生物及其作为β-淀粉样蛋白抑制剂的用途

    公开(公告)号：US07759377B2

    公开(公告)日：2010-07-20

    申请号：US12051924

    申请日：2008-03-20

    申请人： Sylvie Baltzer ,  Marc Pascal ,  Viviane Van Dorsselaer

    发明人： Sylvie Baltzer ,  Marc Pascal ,  Viviane Van Dorsselaer

    IPC分类号： A61K31/426 ,  C07D277/38

    CPC分类号： C07D277/56 ,  C07D277/36 ,  C07D417/04 ,  C07D417/12

    摘要： Compounds of formula (I) as defined herein: inhibit the formation of the β-amyloid peptide (β-A4) and are, therefore, useful in the treatment of pathologies in which a β-amyloid peptide (β-A4) formation inhibitor provides a therapeutic benefit. Particular such pathologies are senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy, cerebrovascular disorders, frontotemporal dementias and Pick's disease, post-traumatic dementias, pathologies linked to neuroinflammatory processes, Huntington's disease and Korsakov's syndrome.

    摘要翻译： 本文定义的式（I）化合物：抑制β-淀粉样蛋白肽（＆bgr; -A4）的形成，因此可用于治疗其中一种淀粉样蛋白肽（＆bgr; -A4 ）形成抑制剂提供治疗益处。 特别的这种病症是老年性痴呆，阿尔茨海默病，唐氏综合征，帕金森病，淀粉样血管病，脑血管病，额颞痴呆和皮克病，创伤后痴呆，与神经炎症过程相关的病症，亨廷顿病和科萨科夫综合征。

    ACYLAMINOTHIAZOLE DERIVATIVES AND USE THEREOF AS BETA-AMYLOID INHIBITORS
    4.
    发明申请
    ACYLAMINOTHIAZOLE DERIVATIVES AND USE THEREOF AS BETA-AMYLOID INHIBITORS 失效
    ACYLAMINOTH唑唑衍生物及其作为β-淀粉样抑制剂的用途

    公开(公告)号：US20060293366A1

    公开(公告)日：2006-12-28

    申请号：US11457490

    申请日：2006-07-14

    申请人： Sylvie Baltzer ,  Marc Pascal ,  Viviane Van Dorsselaer

    发明人： Sylvie Baltzer ,  Marc Pascal ,  Viviane Van Dorsselaer

    IPC分类号： A61K31/4439 ,  A61K31/427 ,  A61K31/426 ,  C07D417/02

    CPC分类号： C07D277/56 ,  C07D277/36 ,  C07D417/04 ,  C07D417/12

    摘要： Compounds of formula (I) as defined herein: inhibit the formation of the β-amyloid peptide (β-A4) and are, therefore, useful in the treatment of pathologies in which a β-amyloid peptide (β-A4) formation inhibitor provides a therapeutic benefit. Particular such pathologies are senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy, cerebrovascular disorders, frontotemporal dementias and Pick's disease, post-traumatic dementias, pathologies linked to neuroinflammatory processes, Huntington's disease and Korsakov's syndrome.

    摘要翻译： 如本文所定义的式（I）化合物：抑制β-淀粉样蛋白肽（β-A4）的形成，因此可用于治疗β-淀粉状蛋白肽（β-A4）形成抑制剂提供的病理学 治疗好处。 特别的这种病症是老年性痴呆，阿尔茨海默病，唐氏综合征，帕金森病，淀粉样血管病，脑血管病，额颞痴呆和皮克病，创伤后痴呆，与神经炎症过程相关的病症，亨廷顿病和科萨科夫综合征。

    Acylaminothiazole derivatives and use thereof as β-amyloid inhibitors
    6.
    发明授权
    Acylaminothiazole derivatives and use thereof as β-amyloid inhibitors 失效
    酰氨基噻唑衍生物及其作为β-淀粉样蛋白抑制剂的用途

    公开(公告)号：US07371770B2

    公开(公告)日：2008-05-13

    申请号：US11457490

    申请日：2006-07-14

    申请人： Sylvie Baltzer ,  Marc Pascal ,  Viviane Van Dorsselaer

    发明人： Sylvie Baltzer ,  Marc Pascal ,  Viviane Van Dorsselaer

    IPC分类号： A61K31/426 ,  C07D277/38 ,  C07D277/46

    CPC分类号： C07D277/56 ,  C07D277/36 ,  C07D417/04 ,  C07D417/12

    摘要： Compounds of formula (I) as defined herein: inhibit the formation of the β-amyloid peptide (β-A4) and are, therefore, useful in the treatment of pathologies in which a β-amyloid peptide (β-A4) formation inhibitor provides a therapeutic benefit. Particular such pathologies are senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy, cerebrovascular disorders, frontotemporal dementias and Pick's disease, post-traumatic dementias, pathologies linked to neuroinflammatory processes, Huntington's disease and Korsakov's syndrome.

    摘要翻译： 如本文所定义的式（I）化合物：抑制β-淀粉样蛋白肽（β-A4）的形成，因此可用于治疗β-淀粉状蛋白肽（β-A4）形成抑制剂提供的病理学 治疗好处。 特别的这种病症是老年性痴呆，阿尔茨海默病，唐氏综合征，帕金森病，淀粉样血管病，脑血管病，额颞痴呆和皮克病，创伤后痴呆，与神经炎症过程相关的病症，亨廷顿病和科萨科夫综合征。